In addition, PLXNA3, B2, and B3 had further increased, while NRP2 and PLXNA2 had further decreased expression in metastatic tumors than in primary tumors although none of the differences were significant due to the small number of metastatic tumor samples (n = 7) (Figure 6A). This evidence concerns the gene PLXNA2 and metastatic neoplasm.